<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02989298</url>
  </required_header>
  <id_info>
    <org_study_id>PD registry</org_study_id>
    <nct_id>NCT02989298</nct_id>
  </id_info>
  <brief_title>Peritoneal Dialysis Registration System (PERSIST)</brief_title>
  <official_title>Peritoneal Dialysis Registration System (PERSIST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brief Summary: The investigators are registering all PD patients at recruited hospitals and
      developing a PD database in China. Patients will be followed up every 3 months, and both
      baseline and follow-up information will be collected and input into the registration system.
      The patient survival, technical survival, peritonitis rate, longitudinal changes of residual
      renal function and peritoneum function, and quality of life for PD patients, etc, will be
      compared using the PD database.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed Description: The investigators are registering all end stage renal disease (ESRD)
      patients receiving peritoneal dialysis (PD) treatment, and developing a PD database in China.
      Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking,
      drinking, and education, etc), clinical characteristics (primary cause of ESRD, dialysis
      prescription, patient's condition and lab measurements of serum, urine, and dialysate), drug
      information, complications and scores of quality of life at the baseline will be collected.
      Patients will be followed up every 3 months. Demographic and clinical characteristics,
      complications, drug information of patients will be collected at each visit. The patients'
      clinical outcomes, such as mortality (including all-cause mortality and cardiovascular
      disease mortality), technical survival, kidney transplantation, transfer to hemodialysis,
      hospitalization, occurrence of peritonitis, etc. were also followed up till the end of the
      study. The data of patient survival, technical survival, peritonitis rate, hospitalization
      rate, clinical lab parameters, longitudinal changes of residual renal function and peritoneum
      function, peritonitis rate, hospitalization rate, clinical lab parameters and quality of life
      for PD patients will be analyzed using the PD database.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Patient survival of PD patients</measure>
    <time_frame>10 years</time_frame>
    <description>Patient survival including all-cause and cardiovascular mortality.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical survival of PD patients</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>ESRD</condition>
  <condition>Disorders Associated With Peritoneal Dialysis</condition>
  <arm_group>
    <arm_group_label>PD patients</arm_group_label>
    <description>End stage renal disease patients receiving peritoneal dialysis treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Registration of all PD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitalsï¼Œwhich have signed the contract in China.</description>
    <arm_group_label>PD patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The serum, urine, DNA and peritoneum tissue will be collected.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        ESRD patients receiving PD treatment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:PD patients -

        Exclusion Criteria:No
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xueqing Yu, M.D. &amp; Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xueqing Yu, M.D. &amp; Ph.D.</last_name>
    <phone>8620-87766335</phone>
    <email>yuxq@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiao Yang, M.D. &amp; Ph.D.</last_name>
    <phone>8620-87755766</phone>
    <phone_ext>8843</phone_ext>
    <email>yangxsysu@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xueqing Yu, M.D. &amp; Ph.D</last_name>
      <phone>8620-87766335</phone>
      <email>yuxq@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2016</study_first_submitted>
  <study_first_submitted_qc>December 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2016</study_first_posted>
  <last_update_submitted>January 21, 2018</last_update_submitted>
  <last_update_submitted_qc>January 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Xue Qing Yu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Peritoneal Dialysis (PD)</keyword>
  <keyword>Residual renal function</keyword>
  <keyword>Peritoneum function</keyword>
  <keyword>Peritonitis rate</keyword>
  <keyword>Technical survival</keyword>
  <keyword>Patient survival</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

